Compugen (CGEN) Revenue (2009 - 2026)
Compugen (CGEN) posted quarterly Revenue of $2.2 million for Q1 2026, down 4.73% year-over-year from $2.3 million in Q1 2025, and down 96.77% on a QoQ basis from $67.3 million in Q4 2025.
Compugen (CGEN) Revenue (2009 - 2026) Analysis & Trends
Compugen has reported Revenue for 15 years, with the latest figure at $2.2 million in Q1 2026.
- Revenue for Q1 2026 came in at $2.2 million, down 4.73% year-over-year; the trailing twelve-month figure through Mar 2026 was $72.7 million (up 163.35% YoY), and the FY2025 annual result was $72.8 million, up 161.14% from the prior year.
- Revenue declined to $2.2 million in Q1 2026, from $67.3 million in the prior quarter.
- Over five years, Revenue peaked at $67.3 million in Q4 2025 and troughed at $1.3 million in Q2 2025.
- A 5-year average of $13.1 million and a median of $2.6 million in 2024 frame the typical range for Revenue.
- The widest annual swing landed in 2024, when Revenue tumbled 95.6%; it then surged 4477.29% in 2025.
- A 5-year view of Revenue shows it stood at $7.5 million in 2022, then surged by 346.12% to $33.5 million in 2023, then tumbled by 95.6% to $1.5 million in 2024, then surged by 4477.29% to $67.3 million in 2025, then plunged by 96.77% to $2.2 million in 2026.
- Per Business Quant data, the three most recent Revenue figures were $2.2 million in Q1 2026, $67.3 million in Q4 2025, and $1.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.56 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.71 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3,001.92 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 674.14 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.29 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 425.49 Mn |
| 10 | Compugen | 227.88 Mn | 136.13 Mn | 352,000.00 | 2.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.18 Mn |
| Dec 31, 2025 | 67.33 Mn |
| Sep 30, 2025 | 1.89 Mn |
| Jun 30, 2025 | 1.26 Mn |
| Mar 31, 2025 | 2.28 Mn |
| Dec 31, 2024 | 1.47 Mn |
| Sep 30, 2024 | 17.13 Mn |
| Jun 30, 2024 | 6.70 Mn |
| Mar 31, 2024 | 2.56 Mn |
| Dec 31, 2023 | 33.46 Mn |
| Dec 31, 2022 | 7.50 Mn |
| Sep 30, 2021 | 6.00 Mn |
| Dec 31, 2020 | 2.00 Mn |
| Sep 30, 2018 | 7.80 Mn |
| Dec 31, 2016 | 53,000.00 |
| Sep 30, 2016 | 70,000.00 |
| Jun 30, 2016 | 496,000.00 |
| Mar 31, 2016 | 93,000.00 |
| Dec 31, 2015 | 8.31 Mn |
| Sep 30, 2015 | 229,000.00 |